OBJECTIVES: To examine the relationship between 6-month medication adherence and 1-year downstream heart disease-related readmission among patients who survived a myocardial infarction (MI). STUDY DESIGN: Retrospective, nested case-control analysis of Medicare fee-for-service beneficiaries who were discharged alive post MI in 2008 (n = 168,882). METHODS: Patients in the case group had their first heart-disease-related readmission post MI discharge during the 6-to-9-month period or the 9-to-12-month period. We then used propensity score matching to identify patients in the control group who had similar characteristics, but did not have a readmission in the same time window. Adherence was defined as the average 6-month medication possession ratio (MPR) prior to the first date of the time-window defining readmission. RESULTS: After controlling for demographics, insurance coverage, and clinical characteristics, patients who had a heart-disease-related readmission had worse adherence, with MPRs of 0.70 and 0.74 in the case and control groups, respectively. Odds ratio of MPR ≥ 0.75 was 0.79 (95% CI, 0.75-0.83) among those with a readmission relative to those without. CONCLUSIONS: Our study shows that better 6-month medication adherence may reduce heart-disease-related readmissions within a year after an MI.
OBJECTIVES: To examine the relationship between 6-month medication adherence and 1-year downstream heart disease-related readmission among patients who survived a myocardial infarction (MI). STUDY DESIGN: Retrospective, nested case-control analysis of Medicare fee-for-service beneficiaries who were discharged alive post MI in 2008 (n = 168,882). METHODS:Patients in the case group had their first heart-disease-related readmission post MI discharge during the 6-to-9-month period or the 9-to-12-month period. We then used propensity score matching to identify patients in the control group who had similar characteristics, but did not have a readmission in the same time window. Adherence was defined as the average 6-month medication possession ratio (MPR) prior to the first date of the time-window defining readmission. RESULTS: After controlling for demographics, insurance coverage, and clinical characteristics, patients who had a heart-disease-related readmission had worse adherence, with MPRs of 0.70 and 0.74 in the case and control groups, respectively. Odds ratio of MPR ≥ 0.75 was 0.79 (95% CI, 0.75-0.83) among those with a readmission relative to those without. CONCLUSIONS: Our study shows that better 6-month medication adherence may reduce heart-disease-related readmissions within a year after an MI.
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: M Christopher Roebuck; Joshua N Liberman; Marin Gemmill-Toyama; Troyen A Brennan Journal: Health Aff (Millwood) Date: 2011-01 Impact factor: 6.301
Authors: Yuting Zhang; Judith R Lave; Julie M Donohue; Michael A Fischer; Michael E Chernew; Joseph P Newhouse Journal: Med Care Date: 2010-05 Impact factor: 2.983
Authors: Niteesh K Choudhry; Jerry Avorn; Robert J Glynn; Elliott M Antman; Sebastian Schneeweiss; Michele Toscano; Lonny Reisman; Joaquim Fernandes; Claire Spettell; Joy L Lee; Raisa Levin; Troyen Brennan; William H Shrank Journal: N Engl J Med Date: 2011-11-14 Impact factor: 91.245
Authors: Barbara Riegel; Alisa Stephens-Shields; Anne Jaskowiak-Barr; Marguerite Daus; Stephen E Kimmel Journal: Pharmacoepidemiol Drug Saf Date: 2020-03-31 Impact factor: 2.890
Authors: Fatima Rodriguez; David J Maron; Joshua W Knowles; Salim S Virani; Shoutzu Lin; Paul A Heidenreich Journal: JAMA Cardiol Date: 2019-03-01 Impact factor: 14.676
Authors: Ahmed N Mahmoud; Islam Y Elgendy; Mohammad K Mojadidi; Siddharth A Wayangankar; Anthony A Bavry; R David Anderson; Hani Jneid; Carl J Pepine Journal: J Am Heart Assoc Date: 2018-03-23 Impact factor: 5.501
Authors: Jennifer A Rymer; Eileen Fonseca; Durgesh D Bhandary; Deepa Kumar; Naeem D Khan; Tracy Y Wang Journal: J Am Heart Assoc Date: 2020-12-21 Impact factor: 5.501
Authors: Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang Journal: J Am Heart Assoc Date: 2017-10-19 Impact factor: 5.501